EKF Diagnostics Holdings plc is engaged in developing, manufacturing and supplying of products and services into the in-vitro diagnostic (IVD) market place. The Company manufactures and sells diagnostic instruments, reagents and certain ancillary products. The Company's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. The Company's Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen C-Line and Biosen S-Line, STAT-Site M B-HB analyzer, sTNFR1 biomarker test kits and Altair 240.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Medical Monitoring Systems
- Sub-Industry: N/A
- Symbol: LON:EKF
- CUSIP: N/A
- Web: www.ekfdiagnostics.com/
- Market Cap: £99.82 million
- Outstanding Shares: 464,262,000
- 50 Day Moving Avg: GBX 20.90
- 200 Day Moving Avg: GBX 19.25
- 52 Week Range: GBX 11 - GBX 22
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Annual Revenue: £38.59 million
- Price / Sales: 2.59
- Book Value: GBX 0.13 per share
- Price / Book: 1.65
- EBIDTA: £4.24 million
- Net Margins: 7.55%
- Return on Equity: 5.09%
- Return on Assets: 3.93%
- Average Volume: 1.10 million shs.
Frequently Asked Questions for Ekf Diagnostics Holding PLC (LON:EKF)
What is Ekf Diagnostics Holding PLC's stock symbol?
Ekf Diagnostics Holding PLC trades on the London Stock Exchange (LON) under the ticker symbol "EKF."
When will Ekf Diagnostics Holding PLC make its next earnings announcement?
Where is Ekf Diagnostics Holding PLC's stock going? Where will Ekf Diagnostics Holding PLC's stock price be in 2017?
1 brokerages have issued twelve-month price objectives for Ekf Diagnostics Holding PLC's stock. Their predictions range from GBX 19 to GBX 21. On average, they expect Ekf Diagnostics Holding PLC's stock price to reach GBX 20 in the next twelve months. View Analyst Ratings for Ekf Diagnostics Holding PLC.
Who are some of Ekf Diagnostics Holding PLC's key competitors?
Some companies that are related to Ekf Diagnostics Holding PLC include Horizon Discovery Group PLC (HZD), Senseonics Holdings (SENS), Kadmon Holdings (KDMN), Asterias Biotherapeutics (AST), Asterias Biotherapeutics (AST), Sinclair Pharma PLC (SPH), OncoCyte Corp (OCX), Synthetic Biologics (SYN), Allergy Therapeutics plc (AGY), Chromadex Corp (CDXC), Nobilis Health Corp (HLTH), MaxCyte (MXCT), Pfenex (PFNX), Vernalis plc (VER), Immunodiagnostic Systems Holdings PLC (IDH), Verastem (VSTM), Navidea Biopharmaceuticals (NAVB) and Ergomed PLC (ERGO).
Who are Ekf Diagnostics Holding PLC's key executives?
Ekf Diagnostics Holding PLC's management team includes the folowing people:
- Julian Huw Baines, Chief Executive Officer, Executive Director
- Richard Anthony Evans, Finance Director, Chief Operating Officer, Executive Director
- Christopher Harwood Bernard Mills, Non-Executive Chairman of the Board
- David Eric Evans, Non-Executive Deputy Chairman of the Board
- Carl Dominic Contadini, Non-Executive Director
- Adam Reynolds, Independent Non-Executive Director
How do I buy Ekf Diagnostics Holding PLC stock?
Shares of Ekf Diagnostics Holding PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Ekf Diagnostics Holding PLC's stock price today?
MarketBeat Community Rating for Ekf Diagnostics Holding PLC (LON EKF)MarketBeat's community ratings are surveys of what our community members think about Ekf Diagnostics Holding PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Ekf Diagnostics Holding PLC stock can currently be purchased for approximately GBX 21.50.
Consensus Ratings for Ekf Diagnostics Holding PLC (LON:EKF) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Buy Rating|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||GBX 20|
Analysts' Ratings History for Ekf Diagnostics Holding PLC (LON:EKF)
(Data available from 6/24/2015 forward)
|4/20/2017||Panmure Gordon||Reiterated Rating||Buy||GBX 21|
|3/20/2017||N+1 Singer||Reiterated Rating||Corporate|
|11/29/2016||FinnCap||Reiterated Rating||Under Review|
Earnings History for Ekf Diagnostics Holding PLC (LON:EKF)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Ekf Diagnostics Holding PLC (LON:EKF)
Current Year EPS Consensus Estimate: $0.75 EPS
Dividend History for Ekf Diagnostics Holding PLC (LON:EKF)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Ekf Diagnostics Holding PLC (LON:EKF)Insider Trades by Quarter for Ekf Diagnostics Holding PLC (LON:EKF)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|3/20/2017||Christopher H B Mills||Insider||Buy||8,000,000||GBX 19||£1,520,000|
|7/15/2016||Mills,Christopher H B||Insider||Buy||9,000,000||GBX 15||£1,350,000|
|6/24/2016||Mills,Christopher H B||Insider||Buy||2,613,957||GBX 12||£313,674.84|
|6/23/2016||Mills,Christopher H B||Insider||Buy||2,000,000||GBX 12||£240,000|
|6/21/2016||Mills,Christopher H B||Insider||Buy||4,500,000||GBX 12||£540,000|
|6/17/2016||Mills,Christopher H B||Insider||Buy||532,781||GBX 12||£63,933.72|
|6/9/2016||Mills,Christopher H B||Insider||Buy||447,666||GBX 12||£53,719.92|
Headline Trends for Ekf Diagnostics Holding PLC (LON:EKF)
Latest Headlines for Ekf Diagnostics Holding PLC (LON:EKF)
Ekf Diagnostics Holding PLC (EKF) Chart for Saturday, June, 24, 2017